Pfizer stock slipped after Q1 results despite an earnings beat as investors weighed falling COVID sales and looming patent expirations.

Pfizer Inc. (NYSE:PFE) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not ...

Pfizer stock (PFE) looks undervalued with a 6.7% dividend, easing LOE headwinds, and strong pipeline execution. Read the ...

Pfizer Inc. (NYSE:PFE) is one of the 10 Best Medical Stocks to Buy Under $30. On April 20, Pfizer Inc. (NYSE:PFE) announced, together with Astellas Pharma Inc., that the US Food and Drug ...

Stock index futures traded lower Wednesday as investors digested a fresh round of corporate earnings and deal announcements.

Pfizer Inc. (NYSE:PFE) is one of the best high volume stocks to invest in according to hedge funds. On May 5, Pfizer reported ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

In addition to Argus Research, Pfizer also received a Buy from BMO Capital’s Evan Seigerman in a report issued yesterday. However, on the same day, TD Cowen maintained a Hold rating on Pfizer (NYSE: ...

SureCare Pharmacy manager Oscar Uribe shows off a package of Pfizer Paxlovid pills inside of Esperanza Health Center in Chicago on Jan. 13, 2022. Pfizer's Paxlovid is a treatment for COVID-19. (Chris ...

Pfizer (PFE) stock gained 0.5% premarket after Q1 EPS of $0.75 topped forecasts. Eliquis drove revenue strength as company ...

Pfizer is looking to newer products and acquisitions to offset a declining Covid business.